Raymond James Financial Services Advisors’s Lexaria Bioscience LEXX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$137K	Sell	44,900 -3,900	-8%	-$11.9K	﹤0.01%	3242
2024 Q2	$136K	Buy	48,800 +9,250	+23%	+$25.7K	﹤0.01%	3188
2024 Q1	$144K	Buy	+39,550	New	+$144K	﹤0.01%	3160